Daniel joined the Bernstein Lab as a research fellow in November 2023. He completed his PhD in the lab of Martin Eilers at JMU Wuerzburg in Germany, studying the molecular mechanisms of the oncoprotein MYC as a stress resilience factor.
Shelby joined the lab as a research fellow in October 2023 after completing her PhD at Harvard University. During her PhD, she used chemical genomics to study 3D chromatin structure. She is interested in understanding and targeting the epigenetic mechanisms that contribute to cancer.
Eran is a Medical Oncology Fellow at Dana-Farber/Mass-General Brigham where he treats patients with melanoma. He completed his M.D. at Harvard Medical School and MIT, and his Ph.D. at Harvard University in biophysics where his work focused on elucidating and studying the somatic mutations that cause cancer, with a focus on melanoma. He joined the … Continued
James is a Pediatric Oncology Fellow at Dana-Farber/Boston Children’s Hospital where he currently treats pediatric patients with cancer diagnoses. He completed his MD/PhD at Case Western Reserve University. His graduate work identified enhancer dysregulation as a driver of osteosarcoma metastasis. He joined the Bernstein lab in September 2022 as a research fellow. His work will apply single cell … Continued
Anne joined the lab as a research fellow in April 2022, after finishing her PhD in the lab of Ton Schumacher at the Netherlands Cancer Institute. During her PhD she dissected the transcriptional states of T cells in tumors using single cell technologies. In the Bernstein lab, she will assess the effects of global changes … Continued